Page last updated: 2024-12-08

santonin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Santonin: Anthelmintic isolated from the dried unexpanded flower heads of Artemisia maritima and other species of Artemisia found principally in Russian and Chinese Turkestan and the Southern Ural region. (From Merck, 11th ed.) [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

FloraRankFlora DefinitionFamilyFamily Definition
ArtemisiagenusA plant genus of the family ASTERACEAE with strong-smelling foliage. It is a source of SANTONIN and other cytotoxic TERPENES.[MeSH]AsteraceaeA large plant family of the order Asterales, subclass Asteridae, class Magnoliopsida. The family is also known as Compositae. Flower petals are joined near the base and stamens alternate with the corolla lobes. The common name of daisy refers to several genera of this family including Aster; CHRYSANTHEMUM; RUDBECKIA; TANACETUM.[MeSH]
Artemisia maritimaspecies[no description available]AsteraceaeA large plant family of the order Asterales, subclass Asteridae, class Magnoliopsida. The family is also known as Compositae. Flower petals are joined near the base and stamens alternate with the corolla lobes. The common name of daisy refers to several genera of this family including Aster; CHRYSANTHEMUM; RUDBECKIA; TANACETUM.[MeSH]
Artemisia maritimaspecies[no description available]AsteraceaeA large plant family of the order Asterales, subclass Asteridae, class Magnoliopsida. The family is also known as Compositae. Flower petals are joined near the base and stamens alternate with the corolla lobes. The common name of daisy refers to several genera of this family including Aster; CHRYSANTHEMUM; RUDBECKIA; TANACETUM.[MeSH]
Artemisia maritimaspecies[no description available]AsteraceaeA large plant family of the order Asterales, subclass Asteridae, class Magnoliopsida. The family is also known as Compositae. Flower petals are joined near the base and stamens alternate with the corolla lobes. The common name of daisy refers to several genera of this family including Aster; CHRYSANTHEMUM; RUDBECKIA; TANACETUM.[MeSH]
Artemisia maritimaspecies[no description available]AsteraceaeA large plant family of the order Asterales, subclass Asteridae, class Magnoliopsida. The family is also known as Compositae. Flower petals are joined near the base and stamens alternate with the corolla lobes. The common name of daisy refers to several genera of this family including Aster; CHRYSANTHEMUM; RUDBECKIA; TANACETUM.[MeSH]

Cross-References

ID SourceID
PubMed CID221071
CHEMBL ID259254
CHEBI ID16363
CHEBI ID26604
SCHEMBL ID1133565
MeSH IDM0019417

Synonyms (137)

Synonym
smr000112520
()-alpha-santonin
MLS002154141
BRD-K58787433-001-05-4
naphtho[1,8(3h,4h)-dione, 3a,5,5a,9b-tetrahydro-3,5a,9-trimethyl-, [3s-(3.alpha.,3a.alpha.,5a.beta.,9b.beta.)]-
eudesma-1, 6.alpha.-hydroxy-3-oxo-, .gamma.-lactone, (11s)-
(-)-santonine
1,3,4,4a,7-hexahydro-1-hydroxy-.alpha., 4a,8-trimethyl-7-oxo-2-naphthaleneacetic acid .gamma.-lactone
wln: t b566 cov lv ihtt&j e1 i1 m1
naphtho[1,8(3h,4h)-dione, 3a,5,5a,9b-tetrahydro-3,5a,9-trimethyl-
santonin
semenen
(-)-santonin
santoninic anhydride
nsc4900 ,
santonine
eudesma-1, 6.alpha.-hydroxy-3-oxo-, .gamma.-lactone, (11s)-(-)-
nsc-4900
11-epiisoeusantona-1, 6.alpha.-hydroxy-3-oxo-, .gamma.-lactone
DIVK1C_006414
KBIO1_001358
SDCCGMLS-0066491.P001
santonin (tn)
santonin (jp17)
D00154
SPECTRUM_000790
SPECTRUM5_000151
BSPBIO_002750
l-alpha-santonin
naphtho(1,2-b)furan-2,8(3h,4h)-dione, 3a,5,5a,9b-tetrahydro-3,5a,9-trimethyl-, (3s,3as,5as,9bs)-
naphtho(1,2-b)puran-2,8(3h,4h)-dione, 3a,5,5a,9b-tetrahydro-3,5a,9-trimethyl-
santoninum
eudesma-1,4-dien-12-oic acid, 6-alpha-hydroxy-3-oxo-, gamma-lactone, (11s)-(-)-
nsc 41311
ai3-19471
(3s,3as,5as,9bs)-2,3,3a,4,5,5a,8,9b-octahydro-3,5a,9-trimethylnaphtho(1,2-b)furan-2,8-dione
11-epiisoeusantona-1,4-dienic acid, 6alpha-hydroxy-3-oxo-, gamma-lactone
(3s)-2,3,3a,4,5,5a,8,9bbeta-octahydro-3,5abeta,9-trimethylnaphtho(1,2-b)furan-2,8-dion
eudesma-1,4-dien-12-oic acid, 6-alpha-hydroxy-3-oxo-, gamma-lactone, (11s)-
naphtho(1,2-b)furan-2,8(3h,4h)-dione, 3a,5,5a,9b-tetrahydro-3,5a,9-trimethyl-, (3s-(3alpha,3aalpha,5abeta,9bbeta))-
einecs 207-560-7
nsc 4900
santonin [jan]
NCGC00016461-01
cas-481-06-1
MEGXP0_001636
(3s,3as,5as,9bs)-3,5a,9-trimethyl-3a,4,5,9b-tetrahydro-3h-benzo[g]benzofuran-2,8-dione
3a,5,5a,9b-tetrahydro-3,5a,9-trimethyl-naphtho[1,2-b]puran-2,8(3h,4h)-dione
BPBIO1_001166
BSPBIO_001060
PRESTWICK2_001070
PRESTWICK3_001070
naphtho[1,2-b]furan-2,8(3h,4h)-dione, 3a,5,5a,9b-tetrahydro-3,5a,9-trimethyl-, (3s,3as,5as,9bs)-
(3s,3as,5as,9bs)-3,5a,9-trimethyl-3a,5,5a,9b-tetrahydronaphtho[1,2-b]furan-2,8(3h,4h)-dione
inchi=1/c15h18o3/c1-8-10-4-6-15(3)7-5-11(16)9(2)12(15)13(10)18-14(8)17/h5,7-8,10,13h,4,6h2,1-3h3/t8-,10-,13-,15-/m0/s
UPCMLD-DP084:001
AB00376930
alpha-santonin ,
481-06-1
C02206
(-)-alpha-santonin, >=99%
UPCMLD-DP084
(-)-alpha-santonin
CHEBI:16363 ,
6alpha-hydroxy-3-oxo-11-epiisoeusantona-1,4-dienic acid gamma-lactone
NCGC00161640-01
(11s)-6alpha-hydroxy-3-oxoeudesma-1,4-dien-12-oic acid gamma-lactone
KBIOGR_002051
KBIO3_002250
KBIO2_006406
KBIO2_003838
KBIO2_001270
KBIOSS_001270
PRESTWICK1_001070
SPECTRUM4_001476
SPBIO_000857
SPECTRUM3_001245
SPBIO_002970
SPECTRUM2_000699
PRESTWICK0_001070
SPECPLUS_000318
SPECTRUM300542
SR-01000635568-1
NCGC00161640-03
NCGC00161640-02
LMPR0103190001
S0521
(3s,3as,5as,9bs)-3a,5,5a,9b-tetrahydro-3,5a,9-trimethylnaphtho[1,2-b]furan-2,8(3h,4h)-dione
a-santonin
CHEMBL259254
HMS1571E22
(3s,3as,5as,9bs)-3,5a,9-trimethyl-3a,4,5,9b-tetrahydro-3h-benzo[g][1]benzofuran-2,8-dione
HMS2098E22
A827469
dtxcid5025312
dtxsid7045312 ,
tox21_110445
HMS2268H12
S3999
CCG-40021
1vl8j38ero ,
santonin [jan:nf]
unii-1vl8j38ero
(3s,5as,9bs)-3a,5,5a,9b-tetrahydro-3,5a,9-trimethylnaphtho[1,2-b]furan-2,8(3h,4h)dione
AKOS015895177
santonin [who-dd]
(3s,3as,5as)-3,5a,9-trimethyl-3a,4,5,5a-tetrahydronaphtho(1,2-b)furan-2,8(3h,9bh)-dione
.alpha.-santonin [mi]
santoninum [hpus]
santonin [mart.]
(3s,3as,5as,9bs)-3a,5,5a,9b-tetrahydro-3,5a,9-trimethylnaphtho(1,2-b)furan-2,8(3h,4h)-dione
tox21_110445_1
NCGC00263447-01
SCHEMBL1133565
mfcd00135865
SR-01000635568-4
sr-01000635568
SR-01000635568-5
(-)-alpha-santonin, analytical standard
santonin, european pharmacopoeia (ep) reference standard
Q413166
HY-B1761
3-(6-nitro-2-oxo-1,3-benzoxazol-3(2h)-yl)propanoicacid
BRD-K58787433-001-08-8
BRD-K58787433-001-12-0
(3s,3as,5as,9bs)-3,5a,9-trimethyl-3a,4,5,5a-tetrahydronaphtho[1,2-b]furan-2,8(3h,9bh)-dione
alpha-santonin; (-)-santonin
CS-0013789
EN300-34530
(3s,3as,5as,9bs)-3,5a,9-trimethyl-2h,3h,3ah,4h,5h,5ah,8h,9bh-naphtho[1,2-b]furan-2,8-dione
(-)- alpha -santonin
gtpl12448
Z359371114
(3s,3as,5as,9bs)-3,5a,9-trimethyl-3a,5,5a,9b-tetrahydronaphtho(1,2-b)furan-2,8(3h,4h)-dione
santonins
santonin (mart.)
chebi:26604

Research Excerpts

Effects

ExcerptReferenceRelevance
"Lumisantonin has inhibited the development of the aerial parts of sorghum and onion by 76 and 67% at 1000 µM respectively."( Novel platensimycin derivatives with herbicidal activity.
Alvarenga, ES; Amorim, KB; Demuner, AJ; Moraes, FC; Pereira-Flores, ME, 2016
)
0.92

Treatment

ExcerptReferenceRelevance
"Treatment with santonin at 5, 10 and 15 mg/kg body weight also reduced the EPG counts."( Comparative efficacy of santonin and piperazine against Neoascaris vitulorum in buffalo calves.
Akhtar, MS; Chattha, MI; Chaudhry, AH, 1982
)
0.91

Compound-Compound Interactions

ExcerptReferenceRelevance
"To evaluate the feasibility of endoscopic gastrostomy combined with magnetic compression techniques in dogs."( [Gastrostomy in dogs with magnetic compression technique combined with endoscopy].
Bai, J; Dong, D; Liu, W; Lyu, Y; Ren, F; Yan, X; Zhang, D; Zhang, J, 2015
)
0.42
"The gastrostomy performed by magnetic compression technique combined with endoscopy is convenient, minimally invasive and safe, which may be used in future clinical practice."( [Gastrostomy in dogs with magnetic compression technique combined with endoscopy].
Bai, J; Dong, D; Liu, W; Lyu, Y; Ren, F; Yan, X; Zhang, D; Zhang, J, 2015
)
0.42

Bioavailability

ExcerptReferenceRelevance
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
santonin
botanical anti-fungal agentHeteroorganic entities that are plant metabolites which have significant antifungal properties.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (4)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency26.06570.001022.650876.6163AID1224838; AID1224839; AID1224893
cytochrome P450 family 3 subfamily A polypeptide 4Homo sapiens (human)Potency11.22020.01237.983543.2770AID1346984
pregnane X nuclear receptorHomo sapiens (human)Potency5.15810.005428.02631,258.9301AID1346982; AID1346985
gemininHomo sapiens (human)Potency0.00460.004611.374133.4983AID624296
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (123)

Assay IDTitleYearJournalArticle
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1347095qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB-EBc1 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347425Rhodamine-PBP qHTS Assay for Modulators of WT P53-Induced Phosphatase 1 (WIP1)2019The Journal of biological chemistry, 11-15, Volume: 294, Issue:46
Physiologically relevant orthogonal assays for the discovery of small-molecule modulators of WIP1 phosphatase in high-throughput screens.
AID1347098qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-SH cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347103qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for OHS-50 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1508630Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID1347092qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for A673 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347154Primary screen GU AMC qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347102qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh18 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347090qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for DAOY cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347105qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for MG 63 (6-TG R) cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347407qHTS to identify inhibitors of the type 1 interferon - major histocompatibility complex class I in skeletal muscle: primary screen against the NCATS Pharmaceutical Collection2020ACS chemical biology, 07-17, Volume: 15, Issue:7
High-Throughput Screening to Identify Inhibitors of the Type I Interferon-Major Histocompatibility Complex Class I Pathway in Skeletal Muscle.
AID1347099qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB1643 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347107qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh30 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347108qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh41 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347093qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-MC cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347096qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for U-2 OS cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347089qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for TC32 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347101qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-12 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347094qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-37 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347091qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SJ-GBM2 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347097qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Saos-2 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347100qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for LAN-5 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347106qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for control Hh wild type fibroblast cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347424RapidFire Mass Spectrometry qHTS Assay for Modulators of WT P53-Induced Phosphatase 1 (WIP1)2019The Journal of biological chemistry, 11-15, Volume: 294, Issue:46
Physiologically relevant orthogonal assays for the discovery of small-molecule modulators of WIP1 phosphatase in high-throughput screens.
AID1347104qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for RD cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID320961Inhibition of serotonin release in bovine platelets2008Journal of medicinal chemistry, Mar-13, Volume: 51, Issue:5
Neural networks as valuable tools to differentiate between sesquiterpene lactones' inhibitory activity on serotonin release and on NF-kappaB.
AID1244476Cytotoxicity against human MCF7 cells assessed as growth inhibition after 48 hrs by sulphorhodamine B assay2015European journal of medicinal chemistry, Aug-28, Volume: 101Design, synthesis and anticancer activity of Michael-type thiol adducts of α-santonin analogue with exocyclic methylene.
AID1315510Immunosuppressive activity in Balb/c mouse B cells assessed as inhibition of LPS-induced cell proliferation at 10 uM after 48 hrs by MTT assay relative to control2016European journal of medicinal chemistry, Sep-14, Volume: 120Synthesis of α-santonin derived acetyl santonous acid triazole derivatives and their bioevaluation for T and B-cell proliferation.
AID721780Immunosuppressive activity in Balb/c mouse B cells assessed as inhibition of LPS-induced cell proliferation at 10'-6 M after 48 hrs by MTT assay2013European journal of medicinal chemistry, Feb, Volume: 60Diminutive effect on T and B-cell proliferation of non-cytotoxic α-santonin derived 1,2,3-triazoles: a report.
AID1428157Immunosuppressive activity in Balb/c mouse T cells assessed as ConA-induced cell proliferation at 100 uM after 48 hrs by MTT assay relative to control2017European journal of medicinal chemistry, Feb-15, Volume: 127Synthesis of α-santonin derivatives for diminutive effect on T and B-cell proliferation and their structure activity relationships.
AID1506558Cytotoxicity against Balb/c mouse B cells assessed as decrease cell survival at 1 uM by MTT assay
AID1244478Cytotoxicity against human HCT116 cells assessed as growth inhibition after 48 hrs by sulphorhodamine B assay2015European journal of medicinal chemistry, Aug-28, Volume: 101Design, synthesis and anticancer activity of Michael-type thiol adducts of α-santonin analogue with exocyclic methylene.
AID1506550Immunosuppressive activity in Balb/c mouse T cells assessed as inhibition of LPS-induced cell proliferation at 1 uM after 48 hrs by MTT assay relative to control
AID1428177Inhibition of TNFalpha (unknown origin) at 10 uM relative to control2017European journal of medicinal chemistry, Feb-15, Volume: 127Synthesis of α-santonin derivatives for diminutive effect on T and B-cell proliferation and their structure activity relationships.
AID721650Cytotoxicity against in Balb/c mouse T cells at 10'-6 M after 48 hrs by MTT assay2013European journal of medicinal chemistry, Feb, Volume: 60Diminutive effect on T and B-cell proliferation of non-cytotoxic α-santonin derived 1,2,3-triazoles: a report.
AID432034Cytotoxicity against human HL60 cells after 72 hrs by MTT assay2009European journal of medicinal chemistry, Sep, Volume: 44, Issue:9
Synthesis and cytotoxic activity of alpha-santonin derivatives.
AID1428175Cytotoxicity against Balb/c mouse B cells assessed as reduction in cell proliferation at 10 uM after 48 hrs by MTT assay2017European journal of medicinal chemistry, Feb-15, Volume: 127Synthesis of α-santonin derivatives for diminutive effect on T and B-cell proliferation and their structure activity relationships.
AID1506542Immunosuppressive activity in Balb/c mouse B cells assessed as inhibition of LPS-induced cell proliferation at 100 uM after 48 hrs by MTT assay relative to control
AID721781Immunosuppressive activity in Balb/c mouse B cells assessed as inhibition of LPS-induced cell proliferation at 10'-5 M after 48 hrs by MTT assay2013European journal of medicinal chemistry, Feb, Volume: 60Diminutive effect on T and B-cell proliferation of non-cytotoxic α-santonin derived 1,2,3-triazoles: a report.
AID432039Cytotoxicity against human OVCAR8 cells after 72 hrs by MTT assay2009European journal of medicinal chemistry, Sep, Volume: 44, Issue:9
Synthesis and cytotoxic activity of alpha-santonin derivatives.
AID1315519Immunostimulatory activity in Balb/c mouse T cells assessed as induction of ConA-induced cell proliferation at 10 uM after 48 hrs by MTT assay relative to control2016European journal of medicinal chemistry, Sep-14, Volume: 120Synthesis of α-santonin derived acetyl santonous acid triazole derivatives and their bioevaluation for T and B-cell proliferation.
AID151991In vitro inhibition against Plasmodium falciparum1988Journal of medicinal chemistry, Jul, Volume: 31, Issue:7
Oxidants, oxidant drugs, and malaria.
AID336310Antimigraine activity in bovine citreated platelet assessed as inhibition of [14C]serotonin release after 6 mins by scintillation counting1992Journal of natural products, Aug, Volume: 55, Issue:8
A bioassay for inhibition of serotonin release from bovine platelets.
AID1428159Immunostimulant activity in Balb/c mouse T cells assessed as ConA-induced cell proliferation at 10 uM after 48 hrs by MTT assay relative to control2017European journal of medicinal chemistry, Feb-15, Volume: 127Synthesis of α-santonin derivatives for diminutive effect on T and B-cell proliferation and their structure activity relationships.
AID1428167Immunosuppressive activity in Balb/c mouse B cells assessed as LPS-induced cell proliferation at 10 uM after 48 hrs by MTT assay relative to control2017European journal of medicinal chemistry, Feb-15, Volume: 127Synthesis of α-santonin derivatives for diminutive effect on T and B-cell proliferation and their structure activity relationships.
AID1428161Immunosuppressive activity in Balb/c mouse T cells assessed as ConA-induced cell proliferation at 1 uM after 48 hrs by MTT assay relative to control2017European journal of medicinal chemistry, Feb-15, Volume: 127Synthesis of α-santonin derivatives for diminutive effect on T and B-cell proliferation and their structure activity relationships.
AID1506552Immunostimulant activity in Balb/c mouse T cells assessed as induction of LPS-induced cell proliferation at 10 uM after 48 hrs by MTT assay relative to control
AID1428174Cytotoxicity against Balb/c mouse B cells assessed as reduction in cell proliferation at 100 uM after 48 hrs by MTT assay2017European journal of medicinal chemistry, Feb-15, Volume: 127Synthesis of α-santonin derivatives for diminutive effect on T and B-cell proliferation and their structure activity relationships.
AID1315504Cytotoxicity against Balb/c mouse B cells assessed as decrease in cell viability at 1 uM after 48 hrs by MTT assay2016European journal of medicinal chemistry, Sep-14, Volume: 120Synthesis of α-santonin derived acetyl santonous acid triazole derivatives and their bioevaluation for T and B-cell proliferation.
AID1506557Cytotoxicity against Balb/c mouse B cells assessed as decrease cell survival at 10 uM by MTT assay
AID432040Cytotoxicity against human A704 cells after 72 hrs by MTT assay2009European journal of medicinal chemistry, Sep, Volume: 44, Issue:9
Synthesis and cytotoxic activity of alpha-santonin derivatives.
AID432033Cytotoxicity against human SF295 cells after 72 hrs by MTT assay2009European journal of medicinal chemistry, Sep, Volume: 44, Issue:9
Synthesis and cytotoxic activity of alpha-santonin derivatives.
AID1428164Immunosuppressive activity in Balb/c mouse B cells assessed as LPS-induced cell proliferation at 100 uM after 48 hrs by MTT assay relative to control2017European journal of medicinal chemistry, Feb-15, Volume: 127Synthesis of α-santonin derivatives for diminutive effect on T and B-cell proliferation and their structure activity relationships.
AID1315521Immunosuppressive activity in Balb/c mouse B cells assessed as inhibition of LPS-induced cell proliferation after 48 hrs by MTT assay relative to control2016European journal of medicinal chemistry, Sep-14, Volume: 120Synthesis of α-santonin derived acetyl santonous acid triazole derivatives and their bioevaluation for T and B-cell proliferation.
AID977599Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID432035Cytotoxicity against human HCT8 cells after 72 hrs by MTT assay2009European journal of medicinal chemistry, Sep, Volume: 44, Issue:9
Synthesis and cytotoxic activity of alpha-santonin derivatives.
AID721783Immunosuppressive activity in Balb/c mouse T cells assessed as inhibition of concanavalin A-induced cell proliferation at 10'-6 M after 48 hrs by MTT assay2013European journal of medicinal chemistry, Feb, Volume: 60Diminutive effect on T and B-cell proliferation of non-cytotoxic α-santonin derived 1,2,3-triazoles: a report.
AID432037Cytotoxicity against human UACC257 cells after 72 hrs by MTT assay2009European journal of medicinal chemistry, Sep, Volume: 44, Issue:9
Synthesis and cytotoxic activity of alpha-santonin derivatives.
AID432036Cytotoxicity against human MDA-MB-435 cells after 72 hrs by MTT assay2009European journal of medicinal chemistry, Sep, Volume: 44, Issue:9
Synthesis and cytotoxic activity of alpha-santonin derivatives.
AID1315505Cytotoxicity against Balb/c mouse T cells assessed as decrease in cell viability at 100 uM after 48 hrs by MTT assay2016European journal of medicinal chemistry, Sep-14, Volume: 120Synthesis of α-santonin derived acetyl santonous acid triazole derivatives and their bioevaluation for T and B-cell proliferation.
AID1428176Cytotoxicity against Balb/c mouse B cells assessed as reduction in cell proliferation at 1 uM after 48 hrs by MTT assay2017European journal of medicinal chemistry, Feb-15, Volume: 127Synthesis of α-santonin derivatives for diminutive effect on T and B-cell proliferation and their structure activity relationships.
AID1506555Cytotoxicity against Balb/c mouse T cells assessed as decrease in cell survival at 1 uM by MTT assay
AID1315507Cytotoxicity against Balb/c mouse T cells assessed as decrease in cell viability at 1 uM after 48 hrs by MTT assay2016European journal of medicinal chemistry, Sep-14, Volume: 120Synthesis of α-santonin derived acetyl santonous acid triazole derivatives and their bioevaluation for T and B-cell proliferation.
AID1428173Cytotoxicity against Balb/c mouse T cells assessed as reduction in cell proliferation at 1 uM after 48 hrs by MTT assay2017European journal of medicinal chemistry, Feb-15, Volume: 127Synthesis of α-santonin derivatives for diminutive effect on T and B-cell proliferation and their structure activity relationships.
AID1315503Cytotoxicity against Balb/c mouse B cells assessed as decrease in cell viability at 10 uM after 48 hrs by MTT assay2016European journal of medicinal chemistry, Sep-14, Volume: 120Synthesis of α-santonin derived acetyl santonous acid triazole derivatives and their bioevaluation for T and B-cell proliferation.
AID1428169Immunostimulant activity in Balb/c mouse B cells assessed as LPS-induced cell proliferation at 1 uM after 48 hrs by MTT assay relative to control2017European journal of medicinal chemistry, Feb-15, Volume: 127Synthesis of α-santonin derivatives for diminutive effect on T and B-cell proliferation and their structure activity relationships.
AID721648Cytotoxicity against in Balb/c mouse B cells at 10'-6 M after 48 hrs by MTT assay2013European journal of medicinal chemistry, Feb, Volume: 60Diminutive effect on T and B-cell proliferation of non-cytotoxic α-santonin derived 1,2,3-triazoles: a report.
AID697853Inhibition of horse BChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID1506556Cytotoxicity against Balb/c mouse B cells assessed as decrease cell survival at 100 uM by MTT assay
AID1244475Cytotoxicity against human PC3 cells assessed as growth inhibition after 48 hrs by sulphorhodamine B assay2015European journal of medicinal chemistry, Aug-28, Volume: 101Design, synthesis and anticancer activity of Michael-type thiol adducts of α-santonin analogue with exocyclic methylene.
AID1428172Cytotoxicity against Balb/c mouse T cells assessed as reduction in cell proliferation at 10 uM after 48 hrs by MTT assay2017European journal of medicinal chemistry, Feb-15, Volume: 127Synthesis of α-santonin derivatives for diminutive effect on T and B-cell proliferation and their structure activity relationships.
AID432042Cytotoxicity against human PBMC cells after 72 hrs by alamar blue assay2009European journal of medicinal chemistry, Sep, Volume: 44, Issue:9
Synthesis and cytotoxic activity of alpha-santonin derivatives.
AID1506544Immunosuppressive activity in Balb/c mouse B cells assessed as inhibition of LPS-induced cell proliferation at 1 uM after 48 hrs by MTT assay relative to control
AID721777Immunostimulant activity in Balb/c mouse T cells assessed as inhibition of concanavalin A-induced cell proliferation at 10'-5 M after 48 hrs by MTT assay2013European journal of medicinal chemistry, Feb, Volume: 60Diminutive effect on T and B-cell proliferation of non-cytotoxic α-santonin derived 1,2,3-triazoles: a report.
AID1315511Immunosuppressive activity in Balb/c mouse B cells assessed as inhibition of LPS-induced cell proliferation at 1 uM after 48 hrs by MTT assay relative to control2016European journal of medicinal chemistry, Sep-14, Volume: 120Synthesis of α-santonin derived acetyl santonous acid triazole derivatives and their bioevaluation for T and B-cell proliferation.
AID1315502Cytotoxicity against Balb/c mouse B cells assessed as decrease in cell viability at 100 uM after 48 hrs by MTT assay2016European journal of medicinal chemistry, Sep-14, Volume: 120Synthesis of α-santonin derived acetyl santonous acid triazole derivatives and their bioevaluation for T and B-cell proliferation.
AID432038Cytotoxicity against human A549 cells after 72 hrs by MTT assay2009European journal of medicinal chemistry, Sep, Volume: 44, Issue:9
Synthesis and cytotoxic activity of alpha-santonin derivatives.
AID1506553Cytotoxicity against Balb/c mouse T cells assessed as decrease in cell survival at 100 uM by MTT assay
AID1315515Immunosuppressive activity in Balb/c mouse T cells assessed as inhibition of ConA-induced cell proliferation at 1 uM after 48 hrs by MTT assay relative to control2016European journal of medicinal chemistry, Sep-14, Volume: 120Synthesis of α-santonin derived acetyl santonous acid triazole derivatives and their bioevaluation for T and B-cell proliferation.
AID1506543Immunosuppressive activity in Balb/c mouse B cells assessed as inhibition of LPS-induced cell proliferation at 10 uM after 48 hrs by MTT assay relative to control
AID1315512Immunosuppressive activity in Balb/c mouse T cells assessed as inhibition of ConA-induced cell proliferation after 48 hrs by MTT assay relative to control2016European journal of medicinal chemistry, Sep-14, Volume: 120Synthesis of α-santonin derived acetyl santonous acid triazole derivatives and their bioevaluation for T and B-cell proliferation.
AID721653Cytotoxicity against in Balb/c mouse B cells at 10'-4 M after 48 hrs by MTT assay2013European journal of medicinal chemistry, Feb, Volume: 60Diminutive effect on T and B-cell proliferation of non-cytotoxic α-santonin derived 1,2,3-triazoles: a report.
AID721649Cytotoxicity against in Balb/c mouse B cells at 10'-5 M after 48 hrs by MTT assay2013European journal of medicinal chemistry, Feb, Volume: 60Diminutive effect on T and B-cell proliferation of non-cytotoxic α-santonin derived 1,2,3-triazoles: a report.
AID1428171Cytotoxicity against Balb/c mouse T cells assessed as reduction in cell proliferation at 100 uM after 48 hrs by MTT assay2017European journal of medicinal chemistry, Feb-15, Volume: 127Synthesis of α-santonin derivatives for diminutive effect on T and B-cell proliferation and their structure activity relationships.
AID721652Cytotoxicity against in Balb/c mouse T cells at 10'-4 M after 48 hrs by MTT assay2013European journal of medicinal chemistry, Feb, Volume: 60Diminutive effect on T and B-cell proliferation of non-cytotoxic α-santonin derived 1,2,3-triazoles: a report.
AID1315506Cytotoxicity against Balb/c mouse T cells assessed as decrease in cell viability at 10 uM after 48 hrs by MTT assay2016European journal of medicinal chemistry, Sep-14, Volume: 120Synthesis of α-santonin derived acetyl santonous acid triazole derivatives and their bioevaluation for T and B-cell proliferation.
AID370588Transcriptional activation of Gal4(1-147) tagged glucocorticoid receptor in human HeLa cells at 10 uM by luciferase reporter gene assay relative to OxDex-AEEA2009Bioorganic & medicinal chemistry, Feb-01, Volume: 17, Issue:3
Expanding the repertoire of small molecule transcriptional activation domains.
AID1428179Inhibition of TNFalpha (unknown origin) at 1 uM relative to control2017European journal of medicinal chemistry, Feb-15, Volume: 127Synthesis of α-santonin derivatives for diminutive effect on T and B-cell proliferation and their structure activity relationships.
AID721786Immunosuppressive activity in Balb/c mouse T cells assessed as inhibition of concanavalin A-induced cell proliferation at 10'-4 M after 48 hrs by MTT assay2013European journal of medicinal chemistry, Feb, Volume: 60Diminutive effect on T and B-cell proliferation of non-cytotoxic α-santonin derived 1,2,3-triazoles: a report.
AID1315509Immunosuppressive activity in Balb/c mouse B cells assessed as inhibition of LPS-induced cell proliferation at 100 uM after 48 hrs by MTT assay relative to control2016European journal of medicinal chemistry, Sep-14, Volume: 120Synthesis of α-santonin derived acetyl santonous acid triazole derivatives and their bioevaluation for T and B-cell proliferation.
AID1506554Cytotoxicity against Balb/c mouse T cells assessed as decrease in cell survival at 10 uM by MTT assay
AID1244477Cytotoxicity against human A549 cells assessed as growth inhibition after 48 hrs by sulphorhodamine B assay2015European journal of medicinal chemistry, Aug-28, Volume: 101Design, synthesis and anticancer activity of Michael-type thiol adducts of α-santonin analogue with exocyclic methylene.
AID977602Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID432041Cytotoxicity against human PC3 cells after 72 hrs by MTT assay2009European journal of medicinal chemistry, Sep, Volume: 44, Issue:9
Synthesis and cytotoxic activity of alpha-santonin derivatives.
AID1506548Immunosuppressive activity in Balb/c mouse T cells assessed as inhibition of LPS-induced cell proliferation at 100 uM after 48 hrs by MTT assay relative to control
AID721651Cytotoxicity against in Balb/c mouse T cells at 10'-5 M after 48 hrs by MTT assay2013European journal of medicinal chemistry, Feb, Volume: 60Diminutive effect on T and B-cell proliferation of non-cytotoxic α-santonin derived 1,2,3-triazoles: a report.
AID1315508Immunosuppressive activity in Balb/c mouse T cells assessed as inhibition of ConA-induced cell proliferation at 100 uM after 48 hrs by MTT assay relative to control2016European journal of medicinal chemistry, Sep-14, Volume: 120Synthesis of α-santonin derived acetyl santonous acid triazole derivatives and their bioevaluation for T and B-cell proliferation.
AID721782Immunosuppressive activity in Balb/c mouse B cells assessed as inhibition of LPS-induced cell proliferation at 10'-4 M after 48 hrs by MTT assay2013European journal of medicinal chemistry, Feb, Volume: 60Diminutive effect on T and B-cell proliferation of non-cytotoxic α-santonin derived 1,2,3-triazoles: a report.
AID1428178Inhibition of TNFalpha (unknown origin) at 5 uM relative to control2017European journal of medicinal chemistry, Feb-15, Volume: 127Synthesis of α-santonin derivatives for diminutive effect on T and B-cell proliferation and their structure activity relationships.
AID697852Inhibition of electric eel AChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
AID1159550Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening2015Nature cell biology, Nov, Volume: 17, Issue:11
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (166)

TimeframeStudies, This Drug (%)All Drugs %
pre-199086 (51.81)18.7374
1990's7 (4.22)18.2507
2000's24 (14.46)29.6817
2010's40 (24.10)24.3611
2020's9 (5.42)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 45.92

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index45.92 (24.57)
Research Supply Index5.20 (2.92)
Research Growth Index4.79 (4.65)
Search Engine Demand Index70.53 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (45.92)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews8 (4.42%)6.00%
Case Studies1 (0.55%)4.05%
Observational0 (0.00%)0.25%
Other172 (95.03%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]